PROMO!
First order? Get 10% OFF with this code: 1storder
GHK-Cu is a copper–peptide complex comprising glycyl-L-histidyl-L-lysine (GHK) associated with copper, classified as a tripeptide-based copper complex for biochemical research.
GHK-Cu is a copper-binding tripeptide complex formed when glycyl-L-histidyl-L-lysine (GHK) coordinates a copper(II) ion. GHK itself is a naturally occurring tripeptide first identified in human plasma and has subsequently been detected in other biological fluids and tissues. The copper complex is commonly referred to as GHK-Cu, copper tripeptide-1 or copper(II)-GHK.
Structurally, GHK contains three amino acids—glycine, histidine and lysine—whose functional groups provide coordination sites for Cu²⁺. Copper-binding studies have investigated the resulting complex using spectroscopic, electrochemical and structural techniques, demonstrating that metal coordination substantially influences the molecular properties of the peptide.
GHK-Cu has been investigated primarily in experimental research concerning copper homeostasis, extracellular-matrix biology, cellular signalling, gene expression and tissue-remodelling processes. Cell-based studies have examined responses involving fibroblasts and other skin-associated cell types, including changes in extracellular-matrix components and enzymes involved in matrix turnover. Other research has explored antioxidant-associated mechanisms and the ability of the GHK ligand to participate in copper transport and exchange reactions.
Unlike receptor-selective peptide hormones, GHK-Cu does not have a single, universally accepted cognate cell-surface receptor that explains all reported biological observations. Its proposed mechanisms instead involve copper coordination together with multiple cellular and molecular interactions.
GHK-Cu should be analytically separated from uncomplexed GHK for laboratory research since copper coordination influences its physicochemical and spectroscopic properties. Therefore, rather than just being an unaltered synthetic peptide, it is better described as an experimental copper–peptide combination.
GHK-Cu is a coordination complex formed between the tripeptide glycyl-L-histidyl-L-lysine (GHK) and a copper(II) ion (Cu²⁺). The peptide component consists of only three amino-acid residues—glycine, histidine and lysine—making GHK substantially smaller than conventional peptide hormones and protein growth factors. Uncomplexed GHK has a molecular formula of C₁₄H₂₄N₆O₄ and a molecular mass of approximately 340.38 Da.
One of GHK's unique molecular features is its strong affinity for copper. Cu²⁺ coordination involves donor groups in the peptide, namely the nitrogen/oxygen functionality of the peptide backbone, the histidine imidazole nitrogen, and the N-terminal amino group. This produces a unique environment that alters the electrical and spectroscopic properties of the peptide when compared to metal-free GHK.
GHK-Cu is a small, water-compatible and highly polar complex containing several ionisable functional groups. Its overall charge and coordination behavior vary with pH, ionic strength and the existence of competing metal-binding molecules. Unlike larger proteins, it has no disulfide bonds, glycosylation or stable tertiary protein architecture.
An important analytical consideration is that GHK and GHK-Cu are chemically distinct species. Verification of GHK-Cu should therefore establish not only peptide identity but also copper content and coordination state. Techniques such as HPLC and mass spectrometry can characterise the peptide component, while UV-visible, EPR or other spectroscopic methods can provide complementary information concerning Cu²⁺ complex formation.
Experimental studies have examined GHK-Cu in relation to copper complex formation, fibroblast activity, extracellular matrix synthesis, and matrix metalloproteinase expression. Copper-complex formation was associated with the observed biological activity of GHK, while the free lysine side chain was reported to be important for activity.
Extracellular Matrix Synthesis
In cultured fibroblasts, GHK-Cu increased collagen synthesis and stimulated synthesis of glycosaminoglycans, particularly extracellular dermatan sulfate and cell-layer-associated heparan sulfate. Experimental wound models also reported increased type I and type III collagen expression and increased extracellular matrix accumulation.
Matrix Metalloproteinase Expression
GHK-Cu increased MMP-2 levels and MMP-2 mRNA in cultured fibroblasts and increased secretion of TIMP-1 and TIMP-2. Experimental wound studies also reported changes in MMP-2 and MMP-9 expression and activation during the experimental wound-remodeling period.
Growth-Factor Expression
In cultured normal and irradiated human fibroblasts, GHK-Cu increased fibroblast growth and was associated with increased production of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) in irradiated fibroblasts.
This summary reflects findings reported in published preclinical and in vitro research. The original studies supporting this information are listed in the references.
A research area particularly specific to GHK-Cu concerns the coordination of Cu²⁺ by the GHK tripeptide. Spectroscopic, electrochemical and computational approaches have been used to investigate copper-binding affinity, coordination geometry and changes in complex formation under different pH and chemical environments. These studies help distinguish copper-complexed GHK from the metal-free peptide.
GHK-Cu has been extensively investigated in fibroblast-based experimental systems. Studies have examined changes in collagen, glycosaminoglycans and other extracellular-matrix components following exposure to the copper–peptide complex. Researchers have also investigated enzymes involved in matrix synthesis, degradation and remodelling.
The relationship between GHK-Cu and matrix metalloproteinases (MMPs) and their endogenous tissue inhibitors has been studied experimentally. Instead of addressing matrix buildup as a separate process, these investigations examine how the peptide complex may affect the equilibrium between extracellular-matrix synthesis and breakdown.
GHK-Cu has been studied in cell culture and preclinical models during processes related to tissue remodeling and cell migration. Cellular responses during matrix reorganization and repair-associated signaling have been studied using fibroblasts and other skin-associated experimental systems.
Because GHK coordinates a redox-active copper ion, its behaviour has also been investigated in oxidative-stress and copper-redox models. Researchers have examined interactions with reactive oxygen species, oxidative damage and antioxidant-associated molecular processes. These effects are context-dependent because copper chemistry itself can participate in both oxidative and protective reactions.
Transcriptomic and cell-based studies have explored how exposure to GHK and GHK-Cu may influence patterns of gene expression. Researchers have reported changes involving genes associated with extracellular-matrix regulation, cellular stress responses, inflammatory signaling and tissue-remodelling processes. Rather than pointing to one specific transcriptional pathway, the available research suggests that GHK-Cu may be associated with changes across several molecular networks. However, these responses can differ depending on the cell type and experimental conditions, and a single pathway responsible for all reported effects has not been established.
The capacity of small peptides to bind, transport, and exchange copper with biological molecules has been investigated using GHK-Cu as a model. These studies examine whether GHK can affect the availability of Cu2+ for proteins and cellular processes while limiting the quantity of free copper ions.
Analytical research focuses on confirming both components of the GHK-Cu complex. HPLC and mass spectrometry can characterise the GHK component, while UV-visible spectroscopy, electron paramagnetic resonance (EPR) and metal analysis can investigate copper coordination. This is particularly important because uncomplexed GHK and GHK-Cu represent chemically distinct experimental materials.
Analytical verification of GHK-Cu should confirm both the identity of the GHK tripeptide and the presence of coordinated Cu²⁺, as GHK-Cu and metal-free GHK are chemically distinct materials. RP-HPLC can be used to assess the overall chromatographic purity of the sample and detect peptide-related impurities that may be present. LC-MS or high-resolution mass spectrometry can then provide additional confirmation of the GHK component by comparing its observed molecular mass with the expected value. Together, these techniques provide a more complete assessment of the peptide component and help establish the identity and quality of the material being analysed.
The copper content of GHK-Cu should also be measured separately using an elemental analysis technique such as ICP-MS or ICP-OES. This allows the amount of copper present to be determined and compared with the peptide content. However, measuring copper alone does not confirm that the Cu²⁺ ion is properly coordinated with GHK. Spectroscopic methods can thus offer useful supplementary data. While electron paramagnetic resonance (EPR) can offer more in-depth information about the chemical environment and coordination of the Cu2+ ion, UV-visible spectroscopy can show distinctive changes linked to the development of the copper–peptide complex. When combined, these techniques offer more proof that the sample has the desired GHK-Cu complex as opposed to just GHK and free copper.
Therefore, peptide identity, chromatographic purity, copper content, pertinent spectroscopic evidence, batch identification, and the analytical techniques employed should all be recorded in a batch-specific Certificate of Analysis.
Store GHK-Cu according to the specified conditions for the supplied chemical form and batch. Lyophilized GHK-Cu should remain in its original sealed container and be protected from moisture, excessive light, heat, and unnecessary temperature fluctuations. Store the supplied material at 2–8°C. During laboratory handling, keep the container sealed when not in use and minimize unnecessary exposure to environmental conditions.
Human plasma and other biological fluids have been found to contain the naturally occurring tripeptide GHK. Under biological circumstances, it can form the GHK-Cu complex and has a significant affinity for Cu2+. However, regulated copper complexation is typically used after synthetically synthesized GHK to make laboratory-grade GHK-Cu.
GHK (Gly-His-Lys) refers to the metal-free tripeptide, whereas GHK-Cu is the coordination complex formed when GHK binds a copper(II) ion. Copper coordination changes the peptide’s electronic, spectroscopic and physicochemical properties, meaning GHK and GHK-Cu should not be considered chemically or analytically identical.
Cu²⁺ is coordinated by GHK via many donor groups in its molecular structure. The N-terminal amino group, peptide-backbone functionality, and histidine's imidazole nitrogen have all been found to contribute to the complex's stable copper coordination environment. The exact distribution of species bound to copper can change depending on the pH and conditions of the experiment.
The best way to characterize GHK-Cu is as a metal–peptide coordination complex. The three amino acid sequence Gly-His-Lys is its peptide component, and Cu²⁺ is its coordinated metal component. When talking about its molecular structure and analytical verification, this distinction is crucial.
A single, dedicated GHK-Cu cell-surface receptor has not been conclusively established. Research has instead examined copper-dependent molecular interactions, cellular uptake, gene-expression responses and extracellular-matrix-associated mechanisms. It should therefore not be described as acting through one established cognate receptor.
Copper is central to the chemistry of GHK-Cu because coordination with Cu²⁺ changes the peptide’s molecular and spectroscopic properties. Research has examined GHK as a potential participant in copper binding, transport and exchange with other biological molecules, as well as the relationship between copper coordination and cellular responses.
Research involving GHK-Cu has examined matrix metalloproteinase-associated extracellular-matrix remodelling, including collagen-degrading enzymes such as MMP-2 and MMP-9 in some experimental systems. However, findings vary by model, and GHK-Cu should not be characterised simply as a direct inhibitor or activator of a particular MMP without reference to the specific experiment.
When verifying GHK-Cu, it is important to confirm both the identity of the GHK peptide and that copper is correctly associated with it. HPLC and mass spectrometry may be used to characterise the peptide itself, while ICP-MS or ICP-OES can provide an precise measurement of the copper content. Additional techniques, such as UV-visible spectroscopy and EPR, can help provide evidence of how Cu²⁺ is coordinated within the complex. Using several complementary analytical methods provides a clearer overall picture of the material and helps distinguish properly characterised GHK-Cu from uncomplexed GHK or samples containing free, unbound copper.
GHK-Cu is intended for laboratory research and scientific investigation only. It is not for human or animal use, ingestion, administration, diagnosis, treatment, or therapeutic purposes.
Information on this website is provided solely for scientific and technical reference. Descriptions of GHK-Cu and its molecular properties reflect areas studied in published scientific research and should not be interpreted as evidence of clinical efficacy, safety, or suitability for diagnosing, treating, curing, or preventing any disease or medical condition.
